Showing results (1291-1300 of 1,373) with videos related to

Sort By:
Pageof 138
Bone Marrow Transplantation|May 25, 2020
Cost and efficacy of peripheral stem cell mobilization strategies in multiple myelomaZoé Van de Wyngaert, Virginie Nerich, Guillemette Fouquet, et al.
Lancet (London, England)|October 9, 2007
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trialThierry Facon, Jean Yves Mary, Cyrille Hulin, et al.
Blood|October 20, 2020
del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myelomaJill Corre, Aurore Perrot, Denis Caillot, et al.
Cell Reports|May 31, 2024
A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4<sup>+</sup> T cell activationSarah Hulin-Curtis, James K Geary, Bruce J MacLachlan, et al.
Ejhaem|February 2, 2026
Teclistamab in Elderly Patients With Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis of the French RetrosTECtive CohortA Coste, S Godet, S Manier, et al.
European Journal of Haematology|February 14, 2025
Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Lenalidomide, and Dexamethasone: MAIA Final Analysis of Patient-Reported OutcomesAurore Perrot, Thierry Facon, Torben Plesner, et al.
Anaerobe|March 11, 2017
Factors associated with Clostridium difficile infection: A nested case-control study in a three year prospective cohortNagham Khanafer, Philippe Vanhems, Frédéric Barbut, et al.
ESMO Open|May 13, 2025
Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58-UCGI35-REGIRI Unicancer randomised phase II studyE Samalin, L Evesque, A Turpin, et al.
Blood|September 3, 2021
Epidemiological landscape of young patients with multiple myeloma diagnosed before 40 years of age: the French experienceAlexis Caulier, Murielle Roussel, Pierre Morel, et al.
Frontiers in Public Health|January 29, 2025
Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (version 2)Liuyun Wu, Ziyan Lv, Min Chen, et al.
Pageof 138